Abbott LaboratoriesvsSBC Medical Group

ABT and SBC stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$108.52

Value $189B

+1.18%
ABT's page

SBC

SBC Medical Group Holdings Incorporated

$7.35

Value $754M

+37.64%
SBC's page

Abbott Laboratories (ABT) has a market value of $189B and SBC Medical Group (SBC) $754M. Over the last year, with dividends, ABT moved -13.7% and SBC +117.5%. The P/E is 40.1 for ABT and 14.5 for SBC. Dividend yield: ABT 2.32%, SBC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$189B

    SBC$754M

    ABT is 250 times SBC

  • Revenue, 12 months

    ABT$48.2B

    SBC$190M

    ABT is 253 times SBC

  • Net income, 12 months

    ABT$4.7B

    SBC$52M

    ABT is 91 times SBC

  • Operating margin

    ABT13.8%

    SBC39.9%

    26.1 points apart

  • ROIC

    ABT6.3%

    SBC16.3%

    10.0 points apart

  • P/E

    ABT40.1

    SBC14.5

    ABT is 2.8 times SBC

  • Dividend yield

    ABT2.3%

    SBC0.0%

    2.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT+20.7%

SBC-30.9%

50100150202420252026
Returns by period
PeriodABTWith dividendsSBCWith dividends
1 year since November 12, 2025-13.7%Price -15.8%+117.5%Price +117.5%
3 years since November 13, 2023+20.7%+6.5% a yearPrice +13.3%-30.9%-11.6% a yearPrice -30.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesSBCSBC Medical Group

Valuation

ABTSBC
Valuation
Price$108.52$7.35
Market value$189B$754M
Enterprise value (EV)$215B$598M
P/E40.114.5
P/E, 5-year median33.711.6
P/B3.72.6
EV/EBIT32.47.9
Free cash flow yield3.6%13.3%

Results and growth

ABTSBC
Results and growth
Revenue, 12 months$48.2B$190M
Net income, 12 months$4.7B$52M
Free cash flow, 12 months$6.8B$100M
Earnings per share, 12 months$2.69$0.50
Revenue growth, year on year5.7%-15.5%
Revenue growth a year, past+5.1%over 5 years-5.3%over 2 years
EPS growth a year, past+8.3%over 5 years+9.1%over 2 years

Margins and returns on capital

ABTSBC
Margins and returns on capital
Gross margin56.9%72.2%
Operating margin13.8%39.9%
Net margin9.8%27.3%
ROIC6.3%16.3%
ROE9.1%19.9%

Balance sheet

ABTSBC
Balance sheet
Cash$4.3B$199M
Total debt$31.2B$53M
Net debt / EBITDA3.3-2.0
Interest cover6.7×181.9×

Dividends and buybacks

ABTSBC
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%0.7%
Shareholder yield2.8%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or SBC

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or SBC Medical Group?

By market value, Abbott Laboratories ($189B) is about 250.1 times SBC Medical Group ($754M), at today's prices.

How did ABT and SBC stock do over the last 3 years?

Since November 13, 2023, ABT's price moved +13.3% and SBC's -30.9%. With dividends: ABT +20.7% (+6.5% a year), SBC -30.9% (-11.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or SBC?

The dividend yield at today's price is 2.32% for Abbott Laboratories and none for SBC Medical Group. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and SBC?

At today's price, the P/E is 40.1 for ABT and 14.5 for SBC. The median of the last five years was 33.7 and 11.6, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or SBC Medical Group?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 27.3% for SBC Medical Group, and the operating margin 13.8% and 39.9%. Revenue was $48.2B and $190M.

Which is the better investment, Abbott Laboratories or SBC Medical Group?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.